

Cover Story
By Alexandria Carolan
At first glance, the United States Supreme Court’s 303 Creative LLC. v. Elenis ruling has nothing to do with health care—but, looking deeper, experts in oncology and law are sounding alarms that the decision can be used to discriminate against LGBTQ+ patients.
In Brief


Clinical Roundup


Trending Stories
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- California Institute of Regenerative Medicine and Cancer Research: A promise broken?
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology
- Sustaining community oncology through nonprofit structures and shared technology infrastructure















